Skip to main content

Supplementary Figure from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Publication ,  Other
Nixon, AB; Sibley, AB; Liu, Y; Hatch, AJ; Jiang, C; Mulkey, F; Starr, MD; Brady, JC; Niedzwiecki, D; Venook, AP; Baez-Diaz, L; Lenz, H-J ...
March 31, 2023

Supplementary Figure from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Duke Scholars

DOI

Publication Date

March 31, 2023
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nixon, A. B., Sibley, A. B., Liu, Y., Hatch, A. J., Jiang, C., Mulkey, F., … Hurwitz, H. I. (2023). Supplementary Figure from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance). https://doi.org/10.1158/1078-0432.22483458.v1
Nixon, Andrew B., Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey, Mark D. Starr, et al. “Supplementary Figure from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance),” March 31, 2023. https://doi.org/10.1158/1078-0432.22483458.v1.
Nixon AB, Sibley AB, Liu Y, Hatch AJ, Jiang C, Mulkey F, Starr MD, Brady JC, Niedzwiecki D, Venook AP, Baez-Diaz L, Lenz H-J, O’Neil BH, Innocenti F, Meyerhardt JA, O’Reilly EM, Owzar K, Hurwitz HI. Supplementary Figure from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance). 2023.

DOI

Publication Date

March 31, 2023